39,296 Shares in Hill-Rom Holdings, Inc. (NYSE:HRC) Acquired by Ajo LP

AJO LP bought a new stake in Hill-Rom Holdings, Inc. (NYSE:HRC) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 39,296 shares of the medical technology company’s stock, valued at approximately $4,160,000. AJO LP owned approximately 0.06% of Hill-Rom at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of HRC. Securian Asset Management Inc increased its holdings in Hill-Rom by 1.2% during the 4th quarter. Securian Asset Management Inc now owns 8,231 shares of the medical technology company’s stock worth $729,000 after purchasing an additional 100 shares in the last quarter. Mastrapasqua Asset Management Inc. increased its holdings in Hill-Rom by 0.7% during the 4th quarter. Mastrapasqua Asset Management Inc. now owns 14,830 shares of the medical technology company’s stock worth $1,313,000 after purchasing an additional 105 shares in the last quarter. Avitas Wealth Management LLC increased its holdings in Hill-Rom by 0.5% during the 1st quarter. Avitas Wealth Management LLC now owns 22,829 shares of the medical technology company’s stock worth $2,417,000 after purchasing an additional 119 shares in the last quarter. US Bancorp DE increased its holdings in Hill-Rom by 3.2% during the 1st quarter. US Bancorp DE now owns 5,068 shares of the medical technology company’s stock worth $536,000 after purchasing an additional 155 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Hill-Rom by 4.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,400 shares of the medical technology company’s stock worth $390,000 after purchasing an additional 189 shares in the last quarter. 81.29% of the stock is owned by institutional investors and hedge funds.

Several research firms recently commented on HRC. ValuEngine upgraded Hill-Rom from a “hold” rating to a “buy” rating in a research note on Tuesday, June 11th. Zacks Investment Research upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $103.00 target price for the company in a report on Thursday, June 6th. Barclays raised their price objective on shares of Hill-Rom from $103.00 to $108.00 and gave the stock an “equal weight” rating in a report on Monday, April 15th. Finally, Needham & Company LLC restated a “buy” rating and issued a $116.00 price objective on shares of Hill-Rom in a report on Monday, March 11th. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $108.00.

Shares of NYSE HRC traded up $0.37 on Monday, reaching $104.99. 283,200 shares of the company’s stock traded hands, compared to its average volume of 487,072. The stock has a market cap of $6.99 billion, a P/E ratio of 22.10, a price-to-earnings-growth ratio of 1.81 and a beta of 0.92. The company has a current ratio of 1.69, a quick ratio of 1.27 and a debt-to-equity ratio of 1.10. The company has a 50 day moving average of $100.64. Hill-Rom Holdings, Inc. has a 12 month low of $81.82 and a 12 month high of $108.68.

Hill-Rom (NYSE:HRC) last issued its quarterly earnings results on Friday, April 26th. The medical technology company reported $1.14 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.03. Hill-Rom had a net margin of 7.93% and a return on equity of 21.30%. The business had revenue of $714.20 million for the quarter, compared to analysts’ expectations of $705.59 million. During the same quarter last year, the company posted $1.05 EPS. The company’s revenue was up .5% compared to the same quarter last year. Analysts expect that Hill-Rom Holdings, Inc. will post 5.05 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 21st were given a $0.21 dividend. The ex-dividend date was Thursday, June 20th. This represents a $0.84 annualized dividend and a dividend yield of 0.80%. Hill-Rom’s payout ratio is presently 17.68%.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Featured Story: Mutual Funds

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.